Search

Postdoc to study the impact of phage therapy on the transfer of conjugative plasmids within and between species of enteric bacteria using experimental approaches.

Postdoc in phage engineering for therapeutic applications.

Postdoc: Our lab focuses on mutation generation and their impact on evolution and adaption in bacteria and phages, using quantitative approaches such as visualisation of mutations in microfluidic setups. Here, we aim to investigate the orig

PhD project: Machine Learning Approaches to Support the Development of Phage Therapies

PhD candidate to join the Cyanobacterial research group to elucidate the role of bacteriophage encoded auxiliary metabolic genes (AMGs) on pigment biosynthesis and oxygenic photosynthesis during the infection process.

Postdoc to study gut phages interacting with the intestinal barrier in Inflammatory Bowel Disease.

Submit your manuscript here for the March issue of PHAGE Journal! Check out the top 2 downloaded articles from December's Special Issue on Phage Informatics and AI: - From Trees to Clouds: PhageClouds for Fast Comparison of 640,000 Phage

Biological Scientist II: bacteriology and virology research, including phage work.

CDC has some AMAZING new interactive visualizations for Antibiotic Resistance by species, geography, and indication. Great for educating people on how big the problem is. Check it out! — Contributed by Natalie Ma via Twitter

In an effort to help companies navigate the development of their bacteriophage product, IHMA’s VP Global Microbiology Services & CSO, Daniel Sahm has compiled a summary of key considerations to address prior to beginning clinical trials.

Thanks to all who came out to the first iVoM Season 2 event of 2022! Next: Feb 2 from 2-3 PM CET Topic: Phage application in the One Health approach. Speakers: Dr. Cath Rees, Prof. Mariana Piuri, Prof. Lone Brøndsted. If you want to join

IPATH invites the phage therapy community to the virtual screening and discussion event for the new documentary, Salt in My Soul. This film recounts the struggles and feelings of Mallory Smith, who lost her battle with cystic fibrosis and a

Paper: Combination of pre-adapted bacteriophage therapy and antibiotics for treatment of fracture-related infection due to pandrug-resistant Klebsiella pneumoniae. — Anaïs Eskenazi et al

Paper: Lambda phage ‘counts’ the number of coinfecting viruses and then uses this to assess the abundance of potential hosts and decide whether to become dormant. This single-cell tool illuminates how! — Tianyou Yao et al.

Paper: Bacteriostatic antibiotics promote CRISPR-Cas adaptive immunity by enabling increased spacer acquisition — Tatiana Dimitriu et al

Preprint: Multiple phage resistance systems inhibit infection via SIR2-dependent NAD+ depletion — Jeremy Garb et al.

Olivier Zablocki shares an updated ecosystem of microbiome/virome apps and guides (iVirus 2), which are freely available to run on CyVerse & DOE KBase. Learn more with their new perspective piece.

In an effort to help companies navigate the development of their bacteriophage product, IHMA’s VP Global Microbiology Services & CSO, Daniel Sahm has compiled a summary of key considerations to address prior to beginning clinical trials.

A bioreactor should provide the ideal environment for cells (and by extension, phages!). But choosing your setup can be tough. This week, Robert Matthew from Cellexus provides a nice explainer to help you understand your options! The role o

Postdoc in the Anantharaman Lab to develop and apply bioinformatic tools to study ecology, evolution, and diversity of viruses/phage in the environment.